Carlomaurizio Montecucco

InstitutionRheumatology
AddressLombardia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 32 Covid-19 publications, with a maximum of 6 publications in June 2020
    All Publications
    Bar chart showing 193 publications over 19 distinct years, with a maximum of 26 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bugatti S, De Stefano L, Balduzzi S, Greco MI, Luvaro T, Cassaniti I, Bogliolo L, Mazzucchelli I, D'Onofrio B, di Lernia M, Mauric E, Lilleri D, Baldanti F, Manzo A, Montecucco C. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis. Ann Rheum Dis. 2021 12; 80(12):1635-1638. PMID: 34172502.
      Citations: 6     Fields:    Translation:Humans
    2. D'Onofrio B, De Stefano L, Palermo BL, Xoxi B, Manzo A, Montecucco C, Bugatti S. Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19. Ann Rheum Dis. 2021 09; 80(9):1242-1243. PMID: 34039623.
      Citations:    Fields:    Translation:Humans
    3. Bugatti S, Balduzzi S, De Stefano L, Manzo A, Xoxi B, Bogliolo L, Monti S, Delvino P, Montecucco C. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'. Ann Rheum Dis. 2021 10; 80(10):e156. PMID: 33906858.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    4. Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695. PMID: 33635224.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Talarico R, Aguilera S, Alexander T, Amoura Z, Antunes AM, Arnaud L, Avcin T, Beretta L, Bombardieri S, Burmester GR, Cannizzo S, Cavagna L, Chaigne B, Cornet A, Costedoat-Chalumeau N, Doria A, Ferraris A, Fischer-Betz R, Fonseca JE, Frank C, Gaglioti A, Galetti I, Grunert J, Guimarães V, Hachulla E, Houssiau F, Iaccarino L, Krieg T, Limper M, Malfait F, Mariette X, Marinello D, Martin T, Matthews L, Matucci-Cerinic M, Meyer A, Montecucco C, Mouthon L, Müller-Ladner U, Rednic S, Romão VC, Schneider M, Smith V, Sulli A, Tamirou F, Taruscio D, Taulaigo AV, Terol E, Tincani A, Ticciati S, Turchetti G, van Hagen PM, van Laar JM, Vieira A, de Vries-Bouwstra JK, Cutolo M, Mosca M. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021 03; 17(3):177-184. PMID: 33408338.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    6. Cavagna L, Zanframundo G, Codullo V, Pisu MG, Caporali R, Montecucco C. Telemedicine in rheumatology: a reliable approach beyond the pandemic. Rheumatology (Oxford). 2021 01 05; 60(1):366-370. PMID: 32893293.
      Citations: 9     Fields:    Translation:Humans
    7. Favalli EG, Bugatti S, Klersy C, Biggioggero M, Rossi S, De Lucia O, Bobbio-Pallavicini F, Murgo A, Balduzzi S, Caporali R, Montecucco C. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther. 2020 12 30; 22(1):290. PMID: 33380344.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    8. Monti S, Bartoletti A, Bellis E, Delvino P, Montecucco C. Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse. Front Med (Lausanne). 2020; 7:589794. PMID: 33364248.
      Citations: 3     
    9. Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, De Stefano L, Bruno R, Corsico AG, Di Sabatino A, Perlini S, Montecucco C, Caccialanza R. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr. 2021 04; 40(4):2469-2472. PMID: 33187772.
      Citations: 16     Fields:    Translation:Humans
    10. De Stefano L, Bobbio-Pallavicini F, Manzo A, Montecucco C, Bugatti S. A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019. Front Immunol. 2020; 11:572635. PMID: 33123149.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    11. Bugatti S, De Stefano L, Bobbio-Pallavicini F, Montecucco C. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline. RMD Open. 2020 10; 6(3). PMID: 33087414.
      Citations:    Translation:HumansCellsPHPublic Health
    12. Monti S, Montecucco C. Response to: 'Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic' by Lecler et al. Ann Rheum Dis. 2020 Sep 22. PMID: 32963055.
      Citations:    Fields:    
    13. Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, Giorgi V, Batticciotto A, Cappelli A, Balzarini P, Dagna L, Sartorelli S, Ravagnani V, Tamanini S, Farah S, Faggioli P, Castelnovo L, Lurati AM, Galli M, Salaffi F. Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. 2021 01; 116:102545. PMID: 32972804.
      Citations: 9     Fields:    Translation:Humans
    14. Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606. PMID: 32506699.
      Citations: 34     Fields:    Translation:Humans
    15. Ramoni VL, Xoxi B, Beneventi F, Bellingeri C, Montecucco C, Spinillo A. Efficacy of a screening strategy for the detection of rheumatic diseases in early pregnancy during COVID-19 pandemic. Lupus. 2020 11; 29(13):1821-1823. PMID: 32838626.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    16. De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2020 Aug 04. PMID: 32753423.
      Citations: 14     Fields:    
    17. Cavagna L, Seminari E, Zanframundo G, Gregorini M, Di Matteo A, Rampino T, Montecucco C, Pelenghi S, Cattadori B, Pattonieri EF, Vitulo P, Bertani A, Sambataro G, Vancheri C, Biglia A, Bozzalla-Cassione E, Bonetto V, Monti MC, Ticozzelli E, Turco A, Oggionni T, Corsico A, Bertuccio F, Zuccaro V, Codullo V, Morosini M, Marena C, Gnecchi M, Pellegrini C, Meloni F. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy. Microorganisms. 2020 Jun 30; 8(7). PMID: 32629788.
      Citations: 21     
    18. Monti S, Montecucco C. Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al. Ann Rheum Dis. 2021 05; 80(5):e68. PMID: 32591359.
      Citations:    Fields:    Translation:Humans
    19. Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al. Ann Rheum Dis. 2021 05; 80(5):e66. PMID: 32586917.
      Citations:    Fields:    Translation:HumansPHPublic Health
    20. Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al. Ann Rheum Dis. 2020 Jun 05. PMID: 32503850.
      Citations: 2     Fields:    
    21. Monti S, Montecucco C. Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak. Ann Rheum Dis. 2020 Jun 05. PMID: 32503855.
      Citations: 1     Fields:    
    22. Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al. Ann Rheum Dis. 2020 Jun 05. PMID: 32503856.
      Citations: 1     Fields:    
    23. Monti S, Delvino P, Bellis E, Milanesi A, Brandolino F, Montecucco C. Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis. Ann Rheum Dis. 2020 12; 79(12):1658-1659. PMID: 32448783.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    24. Monti S, Montecucco C. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al. Ann Rheum Dis. 2021 02; 80(2):e17. PMID: 32434818.
      Citations:    Fields:    Translation:Humans
    25. Monti S, Montecucco C. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al. Ann Rheum Dis. 2021 02; 80(2):e15. PMID: 32414805.
      Citations: 2     Fields:    Translation:Humans
    26. Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Ann Rheum Dis. 2020 10; 79(10):1382-1383. PMID: 32398281.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    27. Colaneri M, Bogliolo L, Valsecchi P, Sacchi P, Zuccaro V, Brandolino F, Montecucco C, Mojoli F, Giusti EM, Bruno R. Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE). Microorganisms. 2020 May 09; 8(5). PMID: 32397399.
      Citations: 85     
    28. Monti S, Montecucco C. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al. Ann Rheum Dis. 2021 01; 80(1):e11. PMID: 32354773.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    29. Monti S, Montecucco C. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al. Ann Rheum Dis. 2021 02; 80(2):e13. PMID: 32354774.
      Citations:    Fields:    Translation:Humans
    30. Monti S, Montecucco C. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al. Ann Rheum Dis. 2021 01; 80(1):e3. PMID: 32340978.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    31. Monti S, Montecucco C. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Ann Rheum Dis. 2020 06; 79(6):e62. PMID: 32327429.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    32. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020 05; 79(5):667-668. PMID: 32241793.
      Citations: 174     Fields:    Translation:HumansCellsPHPublic Health
    Montecucco's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (179)
    Explore
    _
    Co-Authors (179)
    Explore
    _
    Similar People (60)
    Explore
    _